Clinical research progress of fruquintinib in the treatment of malignant tumors (vol 42, pg 612, 2024)

被引:0
|
作者
Zhao, Shihao [1 ]
Wang, Wenhui [2 ]
Li, Jingyi [2 ]
Li, Zhigang [3 ]
Liu, Zhanbo [4 ]
Zhang, Shunchao [5 ]
Chen, Zhaoqi [6 ]
Wang, Hongling [7 ]
Wang, Xiangqi [3 ]
Wang, Juntao [2 ,3 ]
机构
[1] Henan Univ TCM, Affiliated Hosp 3, Sch Acupuncture Moxibust & Tuina, Zhengzhou 450000, Henan, Peoples R China
[2] Henan Univ Chinese Med, Peoples Hosp, Dept oncol, Zhengzhou 450014, Henan, Peoples R China
[3] Henan Univ TCM, Affiliated Hosp 3, Dept Oncol, Zhengzhou 450000, Henan, Peoples R China
[4] Henan Univ Chinese Med, Clin Med Coll 1, Zhengzhou 450046, Henan, Peoples R China
[5] Henan Univ Chinese Med, Publ Dept, Zhengzhou 450046, Henan, Peoples R China
[6] Henan Prov Peoples Hosp, Publ Dept, Zhengzhou 450003, Henan, Peoples R China
[7] Henan Gen Hosp, Dept Oncol, Zhengzhou 450002, Henan, Peoples R China
关键词
D O I
10.1007/s10637-025-01519-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Clinical research progress of fruquintinib in the treatment of malignant tumors
    Zhao, Shihao
    Wang, Wenhui
    Li, Jingyi
    Li, Zhigang
    Liu, Zhanbo
    Zhang, Shunchao
    Chen, Zhaoqi
    Wang, Hongling
    Wang, Xiangqi
    Wang, Juntao
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (06) : 612 - 622
  • [2] Research progress of biomineralization for the diagnosis and treatment of malignant tumors
    Wu, Yulu
    Pan, Xun
    Xie, Huixu
    Que, Lin
    Tang, Xiufa
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] The Great Eclipse ( vol 330, pg 42, 2024)
    Boyle, Rebecca
    SCIENTIFIC AMERICAN, 2024, 330 (06)
  • [4] The Great Eclipse (vol 330, pg 42, 2024)
    Boyle, Rebecca
    SCIENTIFIC AMERICAN, 2024, 331 (01)
  • [5] Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea: A Nonrandomized Controlled Trial (vol 160, pg 612, 2024)
    Wienholtz, Nita K. F.
    Christensen, Casper E.
    Do, Thien P.
    Frifelt, Lith E. W.
    Snellman, Josefin
    Lopez-Lopez, Cristina L.
    Egeberg, Alexander
    Thyssen, Jacob P.
    Ashina, Messoud
    JAMA DERMATOLOGY, 2024, 160 (12) : 1369 - 1369
  • [6] PROGRESS IN TREATMENT OF MALIGNANT TUMORS IN CHILDHOOD
    SCHWEISG.
    JOURNAL BELGE DE RADIOLOGIE, 1968, 51 (06): : R6 - +
  • [7] Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma (vol 42, pg 2702, 2024)
    Bumma, Naresh
    Richter, Joshua
    Jagannath, Sundar
    Lee, Hans C.
    Hoffman, James E.
    Suvannasankha, Attaya
    Zonder, Jeffrey A.
    Shah, Mansi R.
    Lentzsch, Suzanne
    Baz, Rachid
    Maly, Joseph J.
    Namburi, Swathi
    Pianko, Matthew J.
    Ye, Jing Christine
    Wu, Ka Lung
    Silbermann, Rebecca
    Min, Chang-Ki
    Vekemans, Marie-Christiane
    Munder, Markus
    Byun, Ja Min
    Martinez-Lopez, Joaquin
    Cassady, Kaniel
    DeVeaux, Michelle
    Chokshi, Dhruti
    Boyapati, Anita
    Hazra, Anasuya
    Yancopoulos, George D.
    Sirulnik, L. Andres
    Lorenc, Karen Rodriguez
    Kroog, Glenn S.
    Houvras, Yariv
    Dhodapkar, Madhav, V
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (33) : 4001 - 4001
  • [8] Research progress of the SLFN family in malignant tumors
    Yu, Jiale
    Guo, Zhijuan
    Zhang, Junyi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Drying technology development for future starchy staples food processing: Research progress, challenges, and application prospects (vol 42, pg 518, 2024)
    Zhang, Lan
    Zhang, Min
    Zhang, Lihui
    Mujumdar, Arun S.
    Yu, Dongxing
    DRYING TECHNOLOGY, 2024, 42 (06) : 1116 - 1116
  • [10] CML and the WHO: Why? (vol 42, pg 984, 2024)
    Berman, Ellin
    Deininger, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (32) : 3885 - 3885